MS Stock Price Today (September 2026) — Morgan Stanley Analysis & Key Metrics 2026-09-04
Morgan Stanley (MS) is trading at $217.72, up 0.26% today (as of September 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Financial Services growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $236.62 (8.7% upside).
- Volatility remains elevated (21.38% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (28.00% YoY) alongside significant competitive pressures.
MS Stock Analysis: Key Metrics & Valuation (September 2026)
Concise, actionable data for investors
Morgan Stanley - Historical Price & Volume
Market Cap
Enterprise Value: $216.59B
P/E Ratio
Forward P/E: 15.65
Revenue Growth
Year over Year
Analyst Target
+8.7% upside potential
Key Investor Questions About MS
What investors need to know before buying
Based on current market data, MS presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 56.75)
- Fundamentals say: Caution warranted (high leverage concerns)
MS's growth trajectory depends on its ability to expand within the Capital Markets sector while managing margin pressures.
- Future growth will depend on performance in core Capital Markets operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for MS investors include debt exposure and competitive dynamics in the Capital Markets industry.
- $607.50B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Capital Markets.
52-Week Trading Range
Over the past year, MS stock traded between $145.66 and $232.25—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 21.38% annualized volatility and β=1.35, the stock exhibits high sensitivity to market moves—making MS suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Morgan Stanley, Goldman near top roles on Anthropic’s $2tn IPO – report
Morgan Stanley is seen as the leading contender for the “lead left” role, while Goldman is expected to serve as stabilisation agent.
Morgan Stanley delivers bold Carvana stock verdict
Carvana just posted its best quarter ever, yet the stock is down for the year.
Anthropic Weighs Morgan Stanley And Goldman Sachs For Key Roles In $2 Trillion IPO, Says Report
The Claude maker could reportedly file its prospectus as soon as next week, setting the stage for a potential debut in late September or early October.
Morgan Stanley makes a buy call on tumbling retail giant stock
Marmaxx’s performance slipped, but Wall Street believes the diversified business model of TJX will easily absorb the impact.
Market Chatter: Anthropic May Give Morgan Stanley, Goldman Sachs Key Roles in $2 Trillion IPO
Anthropic could give Morgan Stanley (MS) and Goldman Sachs (GS) key roles in handling its market deb
Bapcor (ASX:BAP) Shares See Fair Value Lift As Analysts Reassess Key Assumptions
Bapcor is back in focus after analysts lifted the fair value estimate from A$0.59 to A$0.70, signalling a recalibration of what the stock might be worth under updated assumptions. The shift in the price target reflects recent research that balances a more constructive view on valuation with ongoing caution about execution and external risks. As you read on, you will see how these changes fit into the evolving Bapcor story and what to watch as the narrative develops. Analyst Price Targets...
VA Tech Wabag (NSEI:WABAG) Stock Sees Modest Fair Value Lift On Backlog Confidence
The fair value estimate for VA Tech Wabag is now ₹2,323.67 compared with the prior ₹2,175.89, which represents a modest upward reset of the analyst model. This change aligns with recent Street research that focuses on order book visibility, margin direction and confidence in extending earnings estimates further out in time. As you read on, you will see how this evolving narrative around VA Tech Wabag may shape your own view of the stock’s risk and reward profile. Analyst Price Targets don't...
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.
Could Bank Research Vanish From X?
Morgan Stanley is cracking down on X users sharing its research, filing copyright complaints against at least 16 posts and temporarily locking a prominent strategist's account. The unusual move is raising fresh questions about fair use, and whether Wall Street's favorite forum for sharing charts, research and market ideas could be forced to change.
Anthropic's IPO Push Just Got a $15 Billion Backstop
The company is reportedly preparing an IPO that could rival or exceed SpaceX's
Explore More Analysis for MS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about Morgan Stanley
Morgan Stanley (MS) is currently trading at $217.72. The RSI (14-day) is at 56.7, indicating neutral territory. Wall Street analysts have a consensus "Hold" recommendation. The mean analyst price target of $236.62 implies 8.7% upside from current levels. Volatility is moderate at 21.4% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Morgan Stanley (MS): The trailing P/E ratio is 17.60, which is in line with broader market averages. The forward P/E is 15.65, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 2.04, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 3.21. Price-to-Sales is 4.39. Valuation should be compared to Capital Markets industry peers for context, as different sectors trade at different multiples.
Based on 21 analysts covering MS, the consensus price target is $236.62. This represents a 8.7% upside from the current price of $217.72. The range spans from a low target of $184.00 to a high target of $262.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "Hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Morgan Stanley (MS) pays a dividend with a current yield of approximately 2.11%. The annualized dividend rate is $4.15 per share. The payout ratio is 32.3%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was 2026-07-31T00:00:00.000Z.
Key risks for Morgan Stanley (MS) investors include: 1. Elevated debt levels (D/E ratio of 517.28) which could pressure margins in a rising rate environment. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Capital Markets sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Morgan Stanley's (MS) current debt and financial health profile: Total debt stands at $607.50B. The debt-to-equity ratio is 517.28, which is high and could pose financial risk if earnings decline or borrowing costs increase. The current ratio is 2.00, indicating strong short-term liquidity. The quick ratio is 1.60. The company holds $739.08B in cash and equivalents.